ANI Pharmaceuticals Inc (NASDAQ: ANIP) is 13.26% higher on its value in year-to-date trading and has touched a low of $48.20 and a high of $70.81 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ANIP stock was last observed hovering at around $62.72 in the last trading session, with the day’s loss setting it -0.27%.
Currently trading at $62.45, the stock is 2.98% and 0.86% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.51 million and changing -0.43% at the moment leaves the stock 2.96% off its SMA200. ANIP registered -1.73% loss for a year compared to 6-month loss of -7.71%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -4.98% gain in the last 1 month and extending the period to 3 months gives it a -1.59%, and is 3.19% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.90% over the week and 3.79% over the month.
ANI Pharmaceuticals Inc (ANIP) has around 642 employees, a market worth around $1.31B and $538.95M in sales. Current P/E ratio is 51.06 and Fwd P/E is 11.86. Profit margin for the company is 4.38%. Distance from 52-week low is 29.56% and -11.81% from its 52-week high. The company has generated returns on investments over the last 12 months (3.08%).
The EPS is expected to shrink by -0.32% this year
289.0 institutions hold shares in ANI Pharmaceuticals Inc (ANIP), with institutional investors hold 93.45% of the company’s shares. The shares outstanding are 20.47M, and float is at 17.39M with Short Float at 9.60%. Institutions hold 83.03% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 2.66 million shares valued at $169.17 million. The investor’s holdings represent 13.9092 of the ANIP Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 1.44 million shares valued at $91.73 million to account for 7.542 of the shares outstanding. The other top investors are STATE STREET CORP which holds 0.65 million shares representing 3.3779 and valued at over $41.08 million, while DIMENSIONAL FUND ADVISORS LP holds 3.2998 of the shares totaling 0.63 million with a market value of $40.13 million.
ANI Pharmaceuticals Inc (ANIP) Insider Activity
The most recent transaction is an insider sale by Cook Meredith, the company’s SR. VP, GENERAL COUNSEL & SEC. SEC filings show that Cook Meredith sold 250 shares of the company’s common stock on Aug 13 ’24 at a price of $59.62 per share for a total of $14905.0. Following the sale, the insider now owns 56988.0 shares.
ANI Pharmaceuticals Inc disclosed in a document filed with the SEC on Jul 18 ’24 that Shanmugam Muthusamy (HEAD OF R&D, COO-NOVITIUM OPS) sold a total of 2,743 shares of the company’s common stock. The trade occurred on Jul 18 ’24 and was made at $62.00 per share for $0.17 million. Following the transaction, the insider now directly holds 0.63 million shares of the ANIP stock.
Still, SEC filings show that on Jul 16 ’24, Shanmugam Muthusamy (HEAD OF R&D, COO-NOVITIUM OPS) disposed off 22,000 shares at an average price of $64.27 for $1.41 million. The insider now directly holds 649,620 shares of ANI Pharmaceuticals Inc (ANIP).
